
Arkema Downgraded by Morgan Stanley on Fading Acrylic Acid Margins
The investment bank cut its rating on the French chemical company to 'equal-weight' and slashed its price target by 24%, citing a significant reset in earnings estimates driven by normalizing market conditions.







